Biosynthesis of Chuangxinmycin Featuring a Deubiquitinase‐like Sulfurtransferase
Xingwang Zhang,Xiaokun Xu,Cai You,Chaofan Yang,Jiawei Guo,Moli Sang,Ce Geng,Fangyuan Cheng,Lei Du,Yuemao Shen,Sheng Wang,Haidong Lan,Fan Yang,Yuezhong Li,Ya-Jie Tang,Youming Zhang,Xiaoying Bian,Shengying Li,Wei Zhang
DOI: https://doi.org/10.1002/anie.202107745
2021-01-01
Angewandte Chemie
Abstract:The knowledge on sulfur incorporation mechanism involved in sulfur-containing molecule biosynthesis remains limited. Chuangxinmycin is a sulfur-containing antibiotic with a unique thiopyrano[4,3,2-cd]indole (TPI) skeleton and selective inhibitory activity against bacterial tryptophanyl-tRNA synthetase. Despite the previously reported biosynthetic gene clusters and the recent functional characterization of a P450 enzyme responsible for C-S bond formation, the enzymatic mechanism for sulfur incorporation remains unknown. Here, we resolve this central biosynthetic problem by in vitro biochemical characterization of the key enzymes and reconstitute the TPI skeleton in a one-pot enzymatic reaction. We reveal that the JAMM/MPN+ protein Cxm3 functions as a deubiquitinase-like sulfurtransferase to catalyze a non-classical sulfur-transfer reaction by interacting with the ubiquitin-like sulfur carrier protein Cxm4GG. This finding adds a new mechanism for sulfurtransferase in nature.